 | • レポートコード：B-GIR09F2697 • 出版社/出版日：GlobalInfoResearch / 2019年9月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アルツハイマー病治療の世界市場について調べ、まとめました。種類別セグメントは、コリンエステラーゼ阻害剤、NMDAアンタゴニスト等、用途別セグメントは、病院、診断研究所、研究および学術研究所、その他等に区分しました。アルツハイマー病治療の世界市場概観、企業動向、企業別アルツハイマー病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アルツハイマー病治療の市場概観 ・アルツハイマー病治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アルツハイマー病治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・アルツハイマー病治療の世界市場規模 ・アルツハイマー病治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・アルツハイマー病治療のアメリカ市場規模推移 ・アルツハイマー病治療のカナダ市場規模推移 ・アルツハイマー病治療のメキシコ市場規模推移 ・アルツハイマー病治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・アルツハイマー病治療のドイツ市場規模推移 ・アルツハイマー病治療のイギリス市場規模推移 ・アルツハイマー病治療のロシア市場規模推移 ・アルツハイマー病治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・アルツハイマー病治療の日本市場規模推移 ・アルツハイマー病治療の中国市場規模推移 ・アルツハイマー病治療の韓国市場規模推移 ・アルツハイマー病治療のインド市場規模推移 ・アルツハイマー病治療の東南アジア市場規模推移 ・アルツハイマー病治療の南米市場分析（ブラジル、アルゼンチン等） ・アルツハイマー病治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・アルツハイマー病治療の種類別分析/販売量、売上、市場シェア（コリンエステラーゼ阻害剤、NMDAアンタゴニスト） ・アルツハイマー病治療の用途別分析/市場規模（病院、診断研究所、研究および学術研究所、その他） ・アルツハイマー病治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・アルツハイマー病治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Alzheimer’s is a chronic neurodegenerative disease that usually starts slowly and worsens over time.
Scope of the Report:
The global Alzheimer’s Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Alzheimer’s Disease Treatments.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Alzheimer’s Disease Treatments market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Alzheimer’s Disease Treatments market by product type and applications/end industries.
Market Segment by Companies, this report covers
Eisai
Forest Laboratories
H. Lundbeck
Johnson and Johnson
Merz Pharma
Novartis
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cholinesterase Inhibitors
NMDA Antagonists
Market Segment by Applications, can be divided into
Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Others
Table of Contents
1 Alzheimer’s Disease Treatments Market Overview
1.1 Product Overview and Scope of Alzheimer’s Disease Treatments
1.2 Classification of Alzheimer’s Disease Treatments by Types
1.2.1 Global Alzheimer’s Disease Treatments Revenue Comparison by Types (2019-2024)
1.2.2 Global Alzheimer’s Disease Treatments Revenue Market Share by Types in 2018
1.2.3 Cholinesterase Inhibitors
1.2.4 NMDA Antagonists
1.3 Global Alzheimer’s Disease Treatments Market by Application
1.3.1 Global Alzheimer’s Disease Treatments Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research and Academic Laboratories
1.3.5 Others
1.4 Global Alzheimer’s Disease Treatments Market by Regions
1.4.1 Global Alzheimer’s Disease Treatments Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Alzheimer’s Disease Treatments Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Alzheimer’s Disease Treatments Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Alzheimer’s Disease Treatments Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Alzheimer’s Disease Treatments Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Alzheimer’s Disease Treatments Status and Prospect (2014-2024)
1.5 Global Market Size of Alzheimer’s Disease Treatments (2014-2024)
2 Manufacturers Profiles
2.1 Eisai
2.1.1 Business Overview
2.1.2 Alzheimer’s Disease Treatments Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eisai Alzheimer’s Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.2 Forest Laboratories
2.2.1 Business Overview
2.2.2 Alzheimer’s Disease Treatments Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Forest Laboratories Alzheimer’s Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.3 H. Lundbeck
2.3.1 Business Overview
2.3.2 Alzheimer’s Disease Treatments Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 H. Lundbeck Alzheimer’s Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.4 Johnson and Johnson
2.4.1 Business Overview
2.4.2 Alzheimer’s Disease Treatments Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson and Johnson Alzheimer’s Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merz Pharma
2.5.1 Business Overview
2.5.2 Alzheimer’s Disease Treatments Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merz Pharma Alzheimer’s Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Alzheimer’s Disease Treatments Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Alzheimer’s Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Alzheimer’s Disease Treatments Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Alzheimer’s Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
3 Global Alzheimer’s Disease Treatments Market Competition, by Players
3.1 Global Alzheimer’s Disease Treatments Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Alzheimer’s Disease Treatments Players Market Share
3.2.2 Top 10 Alzheimer’s Disease Treatments Players Market Share
3.3 Market Competition Trend
4 Global Alzheimer’s Disease Treatments Market Size by Regions
4.1 Global Alzheimer’s Disease Treatments Revenue and Market Share by Regions
4.2 North America Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
4.3 Europe Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
4.5 South America Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
5 North America Alzheimer’s Disease Treatments Revenue by Countries
5.1 North America Alzheimer’s Disease Treatments Revenue by Countries (2014-2019)
5.2 USA Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
5.3 Canada Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
5.4 Mexico Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
6 Europe Alzheimer’s Disease Treatments Revenue by Countries
6.1 Europe Alzheimer’s Disease Treatments Revenue by Countries (2014-2019)
6.2 Germany Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
6.3 UK Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
6.4 France Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
6.5 Russia Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
6.6 Italy Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Alzheimer’s Disease Treatments Revenue by Countries
7.1 Asia-Pacific Alzheimer’s Disease Treatments Revenue by Countries (2014-2019)
7.2 China Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
7.3 Japan Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
7.4 Korea Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
7.5 India Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
8 South America Alzheimer’s Disease Treatments Revenue by Countries
8.1 South America Alzheimer’s Disease Treatments Revenue by Countries (2014-2019)
8.2 Brazil Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
8.3 Argentina Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
8.4 Colombia Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Alzheimer’s Disease Treatments by Countries
9.1 Middle East and Africa Alzheimer’s Disease Treatments Revenue by Countries (2014-2019)
9.2 Saudi Arabia Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
9.3 UAE Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
9.4 Egypt Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
9.5 Nigeria Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
9.6 South Africa Alzheimer’s Disease Treatments Revenue and Growth Rate (2014-2019)
10 Global Alzheimer’s Disease Treatments Market Segment by Type
10.1 Global Alzheimer’s Disease Treatments Revenue and Market Share by Type (2014-2019)
10.2 Global Alzheimer’s Disease Treatments Market Forecast by Type (2019-2024)
10.3 Cholinesterase Inhibitors Revenue Growth Rate (2014-2024)
10.4 NMDA Antagonists Revenue Growth Rate (2014-2024)
11 Global Alzheimer’s Disease Treatments Market Segment by Application
11.1 Global Alzheimer’s Disease Treatments Revenue Market Share by Application (2014-2019)
11.2 Alzheimer’s Disease Treatments Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Diagnostic Laboratories Revenue Growth (2014-2019)
11.5 Research and Academic Laboratories Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Alzheimer’s Disease Treatments Market Size Forecast (2019-2024)
12.1 Global Alzheimer’s Disease Treatments Market Size Forecast (2019-2024)
12.2 Global Alzheimer’s Disease Treatments Market Forecast by Regions (2019-2024)
12.3 North America Alzheimer’s Disease Treatments Revenue Market Forecast (2019-2024)
12.4 Europe Alzheimer’s Disease Treatments Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Alzheimer’s Disease Treatments Revenue Market Forecast (2019-2024)
12.6 South America Alzheimer’s Disease Treatments Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Alzheimer’s Disease Treatments Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Alzheimer's Disease Treatments Picture
Table Product Specifications of Alzheimer's Disease Treatments
Table Global Alzheimer's Disease Treatments and Revenue (Million USD) Market Split by Product Type
Figure Global Alzheimer's Disease Treatments Revenue Market Share by Types in 2018
Figure Cholinesterase Inhibitors Picture
Figure NMDA Antagonists Picture
Table Global Alzheimer's Disease Treatments Revenue (Million USD) by Application (2014-2024)
Figure Alzheimer's Disease Treatments Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Diagnostic Laboratories Picture
Figure Research and Academic Laboratories Picture
Figure Others Picture
Table Global Market Alzheimer's Disease Treatments Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Alzheimer's Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Alzheimer's Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Alzheimer's Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Alzheimer's Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Alzheimer's Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Alzheimer's Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Alzheimer's Disease Treatments Type and Applications
Table Eisai Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Forest Laboratories Basic Information, Manufacturing Base and Competitors
Table Forest Laboratories Alzheimer's Disease Treatments Type and Applications
Table Forest Laboratories Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table H. Lundbeck Alzheimer's Disease Treatments Type and Applications
Table H. Lundbeck Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson and Johnson Alzheimer's Disease Treatments Type and Applications
Table Johnson and Johnson Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Merz Pharma Basic Information, Manufacturing Base and Competitors
Table Merz Pharma Alzheimer's Disease Treatments Type and Applications
Table Merz Pharma Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Alzheimer's Disease Treatments Type and Applications
Table Novartis Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Alzheimer's Disease Treatments Type and Applications
Table Pfizer Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Global Alzheimer's Disease Treatments Revenue (Million USD) by Players (2014-2019)
Table Global Alzheimer's Disease Treatments Revenue Share by Players (2014-2019)
Figure Global Alzheimer's Disease Treatments Revenue Share by Players in 2017
Figure Global Alzheimer's Disease Treatments Revenue Share by Players in 2018
Figure Global Top 5 Players Alzheimer's Disease Treatments Revenue Market Share in 2018
Figure Global Top 10 Players Alzheimer's Disease Treatments Revenue Market Share in 2018
Figure Global Alzheimer's Disease Treatments Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Alzheimer's Disease Treatments Revenue (Million USD) by Regions (2014-2019)
Table Global Alzheimer's Disease Treatments Revenue Market Share by Regions (2014-2019)
Figure Global Alzheimer's Disease Treatments Revenue Market Share by Regions (2014-2019)
Figure Global Alzheimer's Disease Treatments Revenue Market Share by Regions in 2018
Figure North America Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Europe Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure South America Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Table North America Alzheimer's Disease Treatments Revenue by Countries (2014-2019)
Table North America Alzheimer's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure North America Alzheimer's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure North America Alzheimer's Disease Treatments Revenue Market Share by Countries in 2018
Figure USA Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Canada Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Mexico Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Table Europe Alzheimer's Disease Treatments Revenue (Million USD) by Countries (2014-2019)
Figure Europe Alzheimer's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure Europe Alzheimer's Disease Treatments Revenue Market Share by Countries in 2018
Figure Germany Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure UK Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure France Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Russia Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Italy Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Alzheimer's Disease Treatments Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Alzheimer's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Alzheimer's Disease Treatments Revenue Market Share by Countries in 2018
Figure China Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Japan Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Korea Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure India Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Table South America Alzheimer's Disease Treatments Revenue by Countries (2014-2019)
Table South America Alzheimer's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure South America Alzheimer's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure South America Alzheimer's Disease Treatments Revenue Market Share by Countries in 2018
Figure Brazil Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Argentina Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Colombia Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Alzheimer's Disease Treatments Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Alzheimer's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Alzheimer's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Alzheimer's Disease Treatments Revenue Market Share by Countries in 2018
Figure Saudi Arabia Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure UAE Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Egypt Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Nigeria Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Figure South Africa Alzheimer's Disease Treatments Revenue and Growth Rate (2014-2019)
Table Global Alzheimer's Disease Treatments Revenue (Million USD) by Type (2014-2019)
Table Global Alzheimer's Disease Treatments Revenue Share by Type (2014-2019)
Figure Global Alzheimer's Disease Treatments Revenue Share by Type (2014-2019)
Figure Global Alzheimer's Disease Treatments Revenue Share by Type in 2019
Table Global Alzheimer's Disease Treatments Revenue Forecast by Type (2019-2024)
Figure Global Alzheimer's Disease Treatments Market Share Forecast by Type (2019-2024)
Figure Global Cholinesterase Inhibitors Revenue Growth Rate (2014-2019)
Figure Global NMDA Antagonists Revenue Growth Rate (2014-2019)
Table Global Alzheimer's Disease Treatments Revenue by Application (2014-2019)
Table Global Alzheimer's Disease Treatments Revenue Share by Application (2014-2019)
Figure Global Alzheimer's Disease Treatments Revenue Share by Application (2014-2019)
Figure Global Alzheimer's Disease Treatments Revenue Share by Application in 2019
Table Global Alzheimer's Disease Treatments Revenue Forecast by Application (2019-2024)
Figure Global Alzheimer's Disease Treatments Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Diagnostic Laboratories Revenue Growth Rate (2014-2019)
Figure Global Research and Academic Laboratories Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Alzheimer's Disease Treatments Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Alzheimer's Disease Treatments Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Alzheimer's Disease Treatments Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Alzheimer's Disease Treatments Revenue Market Forecast (2019-2024)
Figure Europe Alzheimer's Disease Treatments Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Alzheimer's Disease Treatments Revenue Market Forecast (2019-2024)
Figure South America Alzheimer's Disease Treatments Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Alzheimer's Disease Treatments Revenue Market Forecast (2019-2024)
世界のアルツハイマー病治療薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time. Scope of the Report: The worldwide market for Alzheimer's Disease Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ i…- 世界のサイトメガロウイルス病治療市場予測（～2024年）：企業別、地域別、種類・用途別 Cytomegalovirus disease (CMV) is a viral infection that can affect one part of the body, such as the eyes, or it can spread throughout the body. Scope of the Report: The global Cytomegalovirus Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by th…
- 世界の顧みられない熱帯病（NTD）治療市場予測（～2024年）：企業別、地域別、種類・用途別 Tropical diseases are diseases that are prevalent in or unique to tropical and subtropical regions. The diseases are less prevalent in temperate climates, due in part to the occurrence of a cold season, which controls the insect population by forcing hibernation. Scope of the Report: The global Negl…
- 世界の病気リスクおよび健康診断市場予測（～2024年）：企業別、地域別、種類・用途別 The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrie…
- 世界の疾病リスクおよび健康遺伝子検査市場予測（～2024年）：企業別、地域別、種類・用途別 The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrie…